The Jenex Corporation Provides Update on Proposed Financing

The Jenex Corporation (TSX VENTURE:JEN.H), a company focused on the development
and marketing of cosmeceutical skin-care medical device products based on its
patented thermal therapy technology (the "Company"), today issued a report on
the progress of the Company.


Application for Partial Cease Trade Revocation

The Company has applied for and been granted a partial revocation of the cease
trade order (CTO) issued by the Ontario Securities Commission to enable it to
proceed with a private placement financing to investors in Ontario, described in
greater detail below.


The Company ultimately plans to fulfill its requirements under Canadian
provincial securities legislation to become an issuer in good standing and have
the CTO and similar orders issued by the British Columbia and Alberta securities
commissions fully revoked.


The Company is pursuing a private placement of Units to raise approximately
$250,000 at a price of 1.5 cents per Unit. Each Unit will consist of one common
share and one-half of one common share purchase warrant, each whole warrant
exercisable to acquire one common share for $0.10 for a period of 12 months
following closing. The offering will be subject to a minimum of $150,000 being
raised, failing which all subscription amounts will be returned to subscribers.


The Company plans to use the capital raised to bring all of its continuous
disclosure filings up to date and pay related late filing fees and penalties.


FOR FURTHER INFORMATION PLEASE CONTACT: 
Rob Fia, Chairman
[e-mail]


Peter Shippen, CEO
[e-mail]